Literature DB >> 27497368

Invasive aortic pulse wave velocity as a marker for arterial stiffness predicts outcome of renal sympathetic denervation.

Thomas Okon1, Karoline Röhnert, Thomas Stiermaier, Karl-Philipp Rommel, Ulrike Müller, Karl Fengler, Gerhard Schuler, Steffen Desch, Philipp Lurz.   

Abstract

AIMS: A recurrent finding of trials on renal sympathetic denervation is a certain percentage of non-responders. The aim of this study was to examine the influence of arterial stiffness to predict response. METHODS AND
RESULTS: Eighty-eight patients were included in the study. Arterial stiffness was measured by invasive pulse wave velocity. Antihypertensive medication had to be unchanged during follow-up. Ambulatory blood pressure measurement (ABPM) was used to record blood pressure before and six months after denervation. Fifty-eight patients without changes in medication were included in the final analysis. Responders (n=37; blood pressure reduction -12.8±6.4 mmHg) had a significantly lower pulse wave velocity (14.4±4.4 m/s versus 17.7±4.5 m/s; p=0.009) compared to non-responders (n=21; blood pressure reduction +3.0±4.5 mmHg; p<0.001 for comparison with responders). In multivariate analysis, invasive pulse wave velocity was the only significant predictor of blood pressure reduction after denervation (odds ratio 1.15, 95% confidence interval [CI] 1.014-1.327; p=0.03). Patients with increased stiffness were older (p=0.001), had a higher prevalence of diabetes (p=0.008), more often had isolated systolic hypertension (p=0.007), and had a higher invasive pulse pressure (p<0.001).
CONCLUSIONS: Patients with lower pulse wave velocity showed a significantly better response to denervation. These findings emphasise that pulse wave velocity might be used as a selection criterion for renal denervation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27497368     DOI: 10.4244/EIJV12I5A110

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  12 in total

Review 1.  Patient Selection for Renal Denervation in Hypertensive Patients: What Makes a Good Candidate?

Authors:  Sheran Li; Jacqueline K Phillips
Journal:  Vasc Health Risk Manag       Date:  2022-05-13

Review 2.  Device-based therapies for arterial hypertension.

Authors:  Lucas Lauder; Michel Azizi; Ajay J Kirtane; Michael Böhm; Felix Mahfoud
Journal:  Nat Rev Cardiol       Date:  2020-04-14       Impact factor: 32.419

Review 3.  Renal sympathetic denervation in therapy resistant hypertension - pathophysiological aspects and predictors for treatment success.

Authors:  Karl Fengler; Karl Philipp Rommel; Thomas Okon; Gerhard Schuler; Philipp Lurz
Journal:  World J Cardiol       Date:  2016-08-26

4.  Cardiac magnetic resonance assessment of central and peripheral vascular function in patients undergoing renal sympathetic denervation as predictor for blood pressure response.

Authors:  Karl Fengler; Karl-Philipp Rommel; Stephan Blazek; Maximilian Von Roeder; Christian Besler; Christian Lücke; Matthias Gutberlet; Jennifer Steeden; Michael Quail; Steffen Desch; Holger Thiele; Vivek Muthurangu; Philipp Lurz
Journal:  Clin Res Cardiol       Date:  2018-05-09       Impact factor: 5.460

5.  Comparison of two different radiofrequency ablation systems for renal artery denervation: Evaluation of short-term and long-term follow up.

Authors:  Sara I Al Raisi; Jim Pouliopoulos; Pierre Qian; Patricia King; Karen Byth; Michael T Barry; John Swinnen; Aravinda Thiagalingam; Pramesh Kovoor
Journal:  Catheter Cardiovasc Interv       Date:  2018-12-14       Impact factor: 2.692

6.  Comparison of Long-Term Outcomes for Responders Versus Non-Responders Following Renal Denervation in Resistant Hypertension.

Authors:  Karl Fengler; Paul Reimann; Karl-Philipp Rommel; Karl-Patrik Kresoja; Stephan Blazek; Matthias Unterhuber; Christian Besler; Maximilian von Roeder; Michael Böhm; Steffen Desch; Holger Thiele; Philipp Lurz
Journal:  J Am Heart Assoc       Date:  2021-10-29       Impact factor: 5.501

Review 7.  Present Evidence of Determinants to Predict the Efficacy of Renal Denervation.

Authors:  Hao Zhou; Yanping Xu; Weijie Chen; Liang Wang; Huaan Du; Hang Liu; Zhiyu Ling; Yuehui Yin
Journal:  Int J Hypertens       Date:  2022-08-12       Impact factor: 2.434

8.  Renal denervation improves 24-hour central and peripheral blood pressures, arterial stiffness, and peripheral resistance.

Authors:  Christian Ott; Klaas F Franzen; Tobias Graf; Joachim Weil; Roland E Schmieder; Michael Reppel; Kai Mortensen
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-25       Impact factor: 3.738

9.  Pulse Wave Velocity Predicts Response to Renal Denervation in Isolated Systolic Hypertension.

Authors:  Karl Fengler; Karl-Philipp Rommel; Robert Hoellriegel; Stephan Blazek; Christian Besler; Steffen Desch; Gerhard Schuler; Axel Linke; Philipp Lurz
Journal:  J Am Heart Assoc       Date:  2017-05-17       Impact factor: 5.501

10.  Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.

Authors:  Karl Fengler; Sebastian Ewen; Robert Höllriegel; Karl-Philipp Rommel; Saaraaken Kulenthiran; Lucas Lauder; Bodo Cremers; Gerhard Schuler; Axel Linke; Michael Böhm; Felix Mahfoud; Philipp Lurz
Journal:  J Am Heart Assoc       Date:  2017-08-10       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.